These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3630637)

  • 1. Muscle antibodies in the cerebrospinal fluid from patients with myasthenia gravis.
    Thorlacius S; Aarli JA; Gilhus NE; Hofstad H
    Acta Neurol Scand; 1987 Jun; 75(6):423-6. PubMed ID: 3630637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intrathecal immunoactivation in the patients with myasthenia gravis--autoantibodies in the cerebrospinal fluid].
    Yamanaka N; Araki S
    Rinsho Shinkeigaku; 1989 Jan; 29(1):13-7. PubMed ID: 2743683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte subpopulations and IgG concentrations in cerebrospinal fluid and blood from patients with myasthenia gravis.
    Naess A; Gilhus NE; Aarli JA
    Scand J Immunol; 1980; 11(4):431-6. PubMed ID: 6966819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoactivation in the central nervous system in myasthenia gravis.
    Müller KM; Taskinen E; Lefvert AK; Pirskanen R; Iivanainen M
    J Neurol Sci; 1987 Aug; 80(1):13-23. PubMed ID: 3612179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cerebrospinal fluid in myasthenia gravis.
    Thorlacius S; Aarli JA
    Acta Neurol Scand; 1985 Oct; 72(4):432-6. PubMed ID: 4082909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravis.
    Aarli JA; Mattsson C; Heilbronn E
    Scand J Immunol; 1975; 4(8):849-52. PubMed ID: 1215840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of antibodies in myasthenia gravis.
    De Baets M; Stassen MH
    J Neurol Sci; 2002 Oct; 202(1-2):5-11. PubMed ID: 12220686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic oligoclonal CSF IgG and progressive increase of intrathecal IgG synthesis in a patient with myasthenia gravis treated with thymectomy--a 4-years follow-up.
    Kam-Hansen S
    J Neurol Sci; 1986 Oct; 75(3):285-92. PubMed ID: 3772391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity in myasthenia gravis: clinical correlations of anti-receptor antibody avidity and titer.
    Tindall RS
    Ann N Y Acad Sci; 1981; 377():316-31. PubMed ID: 6803647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine receptor antibody in myasthenia gravis: purification and characterization.
    Lefvert AK; Bergström K
    Scand J Immunol; 1978; 8(6):525-33. PubMed ID: 734356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain.
    Whiting PJ; Cooper J; Lindstrom JM
    J Neuroimmunol; 1987 Oct; 16(2):205-13. PubMed ID: 3624454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nicotinic acetylcholine receptor: structure and autoimmune pathology.
    Conti-Tronconi BM; McLane KE; Raftery MA; Grando SA; Protti MP
    Crit Rev Biochem Mol Biol; 1994; 29(2):69-123. PubMed ID: 8026215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
    Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
    Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of acetylcholine receptor expression in seronegative myasthenia gravis.
    Poea S; Guyon T; Bidault J; Bruand C; Mouly V; Berrih-Aknin S
    Ann Neurol; 2000 Nov; 48(5):696-705. PubMed ID: 11079532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synthesis of IgG and antibodies to AChR by peripheral and thymic lymphocytes.
    Lisak RP; Levinson AI; Zweiman B; Kornstein MJ
    Ann N Y Acad Sci; 1987; 505():39-49. PubMed ID: 3500667
    [No Abstract]   [Full Text] [Related]  

  • 18. ELISA for detection of IgG & IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Khajuria A; Subbalaxmi B; Ahuja GK
    Indian J Med Res; 1986 Feb; 83():187-95. PubMed ID: 3710546
    [No Abstract]   [Full Text] [Related]  

  • 19. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
    Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis.
    Howard FM; Lennon VA; Finley J; Matsumoto J; Elveback LR
    Ann N Y Acad Sci; 1987; 505():526-38. PubMed ID: 3479935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.